Cue Biopharma Inc. (CUE)
NASDAQ: CUE
· Real-Time Price · USD
0.81
0.02 (2.53%)
At close: Aug 15, 2025, 3:59 PM
0.83
2.48%
After-hours: Aug 15, 2025, 06:54 PM EDT
Cue Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -38.9M | -40.58M | -40.67M | -44.61M | -46.96M | -49.97M | -50.73M | -51.89M | -51.84M | -51.86M | -53.01M | -46.8M | -48.84M | -45.91M | -44.16M | -46.88M | -43.92M | -44.47M |
Depreciation & Amortization | 1.62M | 2.38M | 2.35M | 3.44M | 3.42M | 3.4M | 3.44M | 3.17M | 2.85M | 2.38M | 1.81M | -1.5M | -1.72M | -1.79M | -1.78M | 1.2M | 1.15M | 114.46K |
Stock-Based Compensation | 5.75M | 6.24M | 6.85M | 7.36M | 7.85M | 8.13M | 8.18M | 8.22M | 8.21M | 8.48M | 9.5M | 10.36M | 11.55M | 12.09M | 11.52M | 10.82M | 10.07M | 9.74M |
Other Working Capital | -2.07M | -4.09M | -5M | -7.17M | -3.99M | -2.25M | -1.04M | 805.89K | 1.28M | 218.89K | -2.81M | -7.65M | -10.4M | -10.64M | -7.97M | -6.11M | -4.73M | -3.54M |
Other Non-Cash Items | 3.74M | 73K | 74K | 3.02M | 3.08M | 3.05M | 2.9M | -285.78K | -354.78K | -491.78K | -453.78K | -6.7M | -5.49M | -4.22M | -3.04M | 5.38M | 1.87M | 579.77K |
Deferred Income Tax | n/a | n/a | n/a | -2.79M | -2.77M | -2.81M | -2.81M | -20K | -41K | n/a | n/a | 3.04M | 3.03M | 3.01M | 3.01M | -19.31K | 4.69K | 23.69K |
Change in Working Capital | -349K | -2.83M | -4.92M | -4.67M | -3.15M | -715K | -934K | 1.3M | 2.59M | 424.27K | 356.27K | -330.46K | -222.46K | -1.79M | -4.39M | -5.7M | -5.43M | 667.18K |
Operating Cash Flow | -28.14M | -34.72M | -36.33M | -38.26M | -38.53M | -38.91M | -39.96M | -39.52M | -38.59M | -41.07M | -41.81M | -41.94M | -41.69M | -38.62M | -38.84M | -35.19M | -36.25M | -33.35M |
Capital Expenditures | -178K | -161K | -66K | -64K | -65K | -55K | -2K | -2.75K | -80.75K | -145.75K | -170.75K | -170.04K | -105.04K | -292.04K | -913.04K | -1.02M | -1.35M | -1.24M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 2K | 2.21K | 5.21K | 8.21K | 6.21K | 10.01M | 10.01M | 10.02M | 10.02M | -14.97M | -14.97M | -14.99M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | -149K | -149.34K | -29.59M | -29.59M | -29.45M | -29.44M | 419.00 | 419.00 | -4.58K | -4.87K | 72.13K | 73.13K |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | 5M | 10M | 25M | 30M | 54.44M | 49.44M | 34.44M | 19.44M | -10M | -10M | n/a | 20M | 25M | 25M |
Other Investing Acitivies | 98K | 98K | 98K | 97K | n/a | 5M | 5.15M | 10.15M | -19.29M | -24.29M | -24.44M | -29.44M | 5.13K | 21.13K | 26.13K | 15.02M | 14.94M | 14.92M |
Investing Cash Flow | -80K | -63K | 32K | 33K | 4.93M | 9.95M | 25M | 30M | -4.52M | -9.58M | -24.61M | -29.61M | -99.49K | -270.49K | 9.11M | 19M | 23.66M | 23.76M |
Debt Repayment | -3M | -4M | -4M | -4M | -4M | -3M | -2M | -1M | n/a | n/a | 10M | 10M | 10M | 10M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9K | -9K | -200K | -200K | -673K | -673K | -567K | -567K | -120K | -196K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 32.04M | 14.24M | 14.24M | n/a | n/a | 85K | 473K | 27.88M | 27.87M | 27.78M | 27.06M | 12.65K | 372.65K | 681.65K | 1.93M | 1.82M | 2.16M | 45.17M |
Financial Cash Flow | 25.69M | 6.89M | 10.24M | 15.96M | 10.72M | 13.83M | 11.86M | 34.48M | 29.88M | 38.89M | 53.66M | 33.64M | 34M | 33.56M | 19.23M | 12.1M | 26.76M | 59.41M |
Net Cash Flow | -2.54M | -27.89M | -26.05M | -22.27M | -22.87M | -15.14M | -3.1M | 24.97M | -13.22M | -11.76M | -12.76M | -37.91M | -7.79M | -5.33M | -10.5M | -4.1M | 14.17M | 49.83M |
Free Cash Flow | -28.32M | -34.88M | -36.4M | -38.32M | -38.6M | -38.97M | -39.96M | -39.52M | -38.67M | -41.21M | -41.98M | -42.11M | -41.8M | -38.91M | -39.75M | -36.21M | -37.61M | -34.59M |